These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24586047)

  • 1. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.
    Sutherland KD; Song JY; Kwon MC; Proost N; Zevenhoven J; Berns A
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4952-7. PubMed ID: 24586047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.
    Xu X; Rock JR; Lu Y; Futtner C; Schwab B; Guinney J; Hogan BL; Onaitis MW
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4910-5. PubMed ID: 22411819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
    Moghaddam SJ; Li H; Cho SN; Dishop MK; Wistuba II; Ji L; Kurie JM; Dickey BF; Demayo FJ
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):443-53. PubMed ID: 18927348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.
    Mainardi S; Mijimolle N; Francoz S; Vicente-Dueñas C; Sánchez-García I; Barbacid M
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):255-60. PubMed ID: 24367082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
    Kasinski AL; Slack FJ
    Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.
    Nagaraj AS; Lahtela J; Hemmes A; Pellinen T; Blom S; Devlin JR; Salmenkivi K; Kallioniemi O; Mäyränpää MI; Närhi K; Verschuren EW
    Cell Rep; 2017 Jan; 18(3):673-684. PubMed ID: 28099846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
    Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.
    Duan W; Gao L; Kalvala A; Aguila B; Brooks C; Mo X; Ding H; Shilo K; Otterson GA; Villalona-Calero MA
    Int J Cancer; 2019 Nov; 145(9):2418-2426. PubMed ID: 30873587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
    Cho HC; Lai CY; Shao LE; Yu J
    Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
    Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
    Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
    Pan Y; Jiang Y; Tan L; Ravoori MK; Gagea M; Kundra V; Fischer SM; Yang P
    Oncotarget; 2015 Nov; 6(36):38816-26. PubMed ID: 26452035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar type II cells possess the capability of initiating lung tumor development.
    Lin C; Song H; Huang C; Yao E; Gacayan R; Xu SM; Chuang PT
    PLoS One; 2012; 7(12):e53817. PubMed ID: 23285300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.
    Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD
    Toxicology; 2003 May; 187(2-3):217-28. PubMed ID: 12699910
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC
    Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981
    [No Abstract]   [Full Text] [Related]  

  • 15. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.
    Meuwissen R; Linn SC; van der Valk M; Mooi WJ; Berns A
    Oncogene; 2001 Oct; 20(45):6551-8. PubMed ID: 11641780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer.
    Best SA; Kersbergen A; Asselin-Labat ML; Sutherland KD
    Methods Mol Biol; 2018; 1725():15-29. PubMed ID: 29322405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
    Deng H; Ge H; Dubey C; Losmanova T; Medová M; Konstantinidou G; Mutlu SM; Birrer FE; Brodie TM; Stroka D; Wang W; Peng RW; Dorn P; Marti TM
    Cancer Immunol Immunother; 2023 Dec; 72(12):4457-4470. PubMed ID: 37796299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of pre-malignant lesions in a KRAS
    Rakhit CP; Trigg RM; Le Quesne J; Kelly M; Shaw JA; Pritchard C; Martins LM
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30760495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
    Volonte D; Vyas AR; Chen C; Dacic S; Stabile LP; Kurland BF; Abberbock SR; Burns TF; Herman JG; Di YP; Galbiati F
    J Biol Chem; 2018 Feb; 293(5):1794-1809. PubMed ID: 29247004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating the expression of human K-rasG12D stimulates oncogenic transformation in transgenic goat fetal fibroblast cells.
    Gong J; Wang Z; Polejaeva I; Salgia R; Kao CM; Chen CT; Chen G; Chen L
    PLoS One; 2014; 9(3):e90059. PubMed ID: 24594684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.